ArticleNanomaterials (Basel, Switzerland)2020
Peptide-Carbon Quantum Dots conjugate, Derived from Human Retinoic Acid Receptor Responder Protein 2, against Antibiotic-Resistant Gram Positive and Gram Negative Pathogenic Bacteria.
Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 50 citations in OpenAlex.
- Dendrocin ZM1 Nanoconjugates with Carbon Quantum Dots: A ROS-Generating Platform for Combating Multidrug-Resistant Bacteria.International journal of nanomedicine · 2026Article
- The carbon quantum dots: Preparation, antibacterial mechanisms, and application in food packaging.Current research in food science · 2026Review
- Antibacterial carbon dots.Materials today. Bio · 2025Review
- The Molecular Basis of Asthma Exacerbations Triggered by Viral Infections: The Role of Specific miRNAs.International journal of molecular sciences · 2024Review
- Constructing a highly efficient multifunctional carbon quantum dot platform for the treatment of infectious wounds.Regenerative biomaterials · 2024Article
- Application of CRISPR-Cas System to Mitigate Superbug Infections.Microorganisms · 2023Review
- Red emitting carbon dots: surface modifications and bioapplications.Nanoscale advances · 2023Review
- Nanocellulose-Based Passivated-Carbon Quantum Dots (P-CQDs) for Antimicrobial Applications: A Practical Review.Polymers · 2023Review
- Employing Gamma-Ray-Modified Carbon Quantum Dots to Combat a Wide Range of Bacteria.Antibiotics (Basel, Switzerland) · 2023Article
- Carbon Dots for Killing Microorganisms: An Update since 2019.Pharmaceuticals (Basel, Switzerland) · 2022Review
- Biomedical Applications of Quantum Dots: Overview, Challenges, and Clinical Potential.International journal of nanomedicine · 2022Review
- Specific Inhibition of VanZ-Mediated Resistance to Lipoglycopeptide Antibiotics.International journal of molecular sciences · 2021Article
- Characterization of the Molecular Mechanisms of Resistance against DMI Fungicides inJournal of fungi (Basel, Switzerland) · 2021Article
- Carbon Dots as an Emergent Class of Antimicrobial Agents.Nanomaterials (Basel, Switzerland) · 2021Review
- Antibacterial Activity of Nanoparticles.Nanomaterials (Basel, Switzerland) · 2021Article
- Protective Effects of Radix Sophorae Flavescentis Carbonisata-Based Carbon Dots Against Ethanol-Induced Acute Gastric Ulcer in Rats: Anti-Inflammatory and Antioxidant Activities.International journal of nanomedicine · 2021Article
- KCNQ1OT1/miR-18b/HMGA2 axis regulates high glucose-induced proliferation, oxidative stress, and extracellular matrix accumulation in mesangial cells.Molecular and cellular biochemistry · 2021Article
- A Novel Biocompatible Titanium-Gadolinium Quantum Dot as a Bacterial Detecting Agent with High Antibacterial Activity.Nanomaterials (Basel, Switzerland) · 2020Article
- A Novel Ruthenium Based Coordination Compound Against Pathogenic Bacteria.International journal of molecular sciences · 2020Article
- Characterization andFrontiers in microbiology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
Antibiotic-resistant bacterial infections have become global issues for public health, which increases the utter need to develop alternatives to antibiotics. Here, the HSER (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.